Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death
- 31 August 2004
- journal article
- research article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 31 (6) , 747-752
- https://doi.org/10.1016/j.nucmedbio.2004.02.007
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Development and Characterization of Annexin V Mutants with Endogenous Chelation Sites for 99mTcBioconjugate Chemistry, 2000
- Visualisation of cell death in vivo in patients with acute myocardial infarctionThe Lancet, 2000
- Markers of apoptosis in cardiovascular tissues focus on Annexin VCardiovascular Research, 2000
- Death by design: mechanism and control of apoptosisTrends in Cell Biology, 1999
- Anticancer Agents Targeting Signaling Molecules and Cancer Cell Environment: Challenges for Drug Development?JNCI Journal of the National Cancer Institute, 1999
- The Impact of Developmental Biology on Cancer Research: An OverviewCancer and Metastasis Reviews, 1999
- In vivo detection and imaging of phosphatidylserine expression during programmed cell deathProceedings of the National Academy of Sciences, 1998
- Selective Uptake of Radiolabeled Annexin V on Acute Porcine Left Atrial ThrombiCirculation, 1995
- Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.The Journal of Experimental Medicine, 1995
- Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosisBlood, 1994